glucogallin has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albezrah, NKA; Alsubaie, N; Bansal, S; Batiha, GE; Chauhan, S; Dhankhar, S; Dhiman, S; Garg, A; Rohilla, M; Saini, M; Singh, TG | 1 |
| Chang, KC; LaBarbera, DV; Petrash, JM; Snow, A | 1 |
1 review(s) available for glucogallin and Diabetic Retinopathy
| Article | Year |
|---|---|
Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy.
Topics: Animals; Curcumin; Diabetes Mellitus; Diabetic Retinopathy; Humans; Hydrolyzable Tannins; Retina | 2023 |
1 other study(ies) available for glucogallin and Diabetic Retinopathy
| Article | Year |
|---|---|
Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.
Topics: Aldehyde Reductase; Apoptosis; Cell Survival; Cells, Cultured; Diabetic Retinopathy; Enzyme Inhibitors; Epithelial Cells; Glucose; Humans; Hydrolyzable Tannins; Hyperglycemia; Imidazolidines; Membrane Potential, Mitochondrial; Microglia; Reactive Oxygen Species; Retinal Pigments | 2015 |